Nuclear receptors and bone

Annals of the New York Academy of Sciences

Volumn 1116, Issue , 2007, Pages 327-334

  Margolis, Ronald N ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Nuclear Receptor Signaling Atlas; Nuclear receptors; NURSA; Osteoporosis

Indexed keywords

CELL NUCLEUS RECEPTOR; FOLLITROPIN; GLUCOCORTICOID; THYROTROPIN;

BIOINFORMATICS; BIOLOGY; BONE; BONE METABOLISM; COMMUNITY; COMPREHENSION; CONFERENCE PAPER; HEALTH; HOMEOSTASIS; HUMAN; MEDICAL INFORMATION; MEDICINE; MINERAL METABOLISM; OSSIFICATION; OSTEOCLAST; OSTEOPENIA; OSTEOPOROSIS;

EID: 37249013849     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1402.043     Document Type: Conference Paper

References (27)

1. MANGELSDORF, D.J., C. THUMMEL, M. BEATO, et al. 1995. The nuclear receptor superfamily: the second decade. Cell 83: 835-839.
2. LANE, N.E. 2006. Epidemiology, etiology, and diagnosis of osteoporosis. Am. J. Obstet. Gynecol. 194(2 Suppl):s3-s11.
3. SYED, F.A., D.G. FRASER, T.C. SPELSBERG, et al. 2007. Effects of loss of classical estrogen response element signaling on bone in male mice. Endocrinology 148: 1902-1910.
4. EVANS, R.M. 2005. The nuclear receptor superfamily: a rosetta stone for physiology. Mol. Endo. 19: 1429-1438.
5. MOORE, D.D., S. KATO, W. XIE, et al. 2006. International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor. Pharmacol. Rev. 58: 742-759.
6. LONARD, D.M. & B.W. O'MALLEY 2006. The expanding cosmos of nuclear receptor coactivators. Cell 125: 411-414.
7. ROSENFELD, M.G., V.V. LUNYAK & C.K. GLASS. 2006. Sensors and signals: a coactivator/corepressors/epigenetic code for integrating signaling-dependent programs of transcriptional response. Genes Dev. 20: 1405-1428.
8. FU, M., T. SUN, A.L. BOOKOUT, et al. 2005. A nuclear receptor atlas: 3T3-LI adipogenesis. Mol. Endocrinol. 19: 2437-2450.
9. BARISH, G.D., M. DOWNES, W.A. ALAYNICK, et al. 2006. A nuclear receptor atlas: macrophage activation. Mol. Endo. 19: 2466-2477.
10. BOOKOUT, A.L., Y. JEONG, M. DOWNES, et al. 2006. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126: 789-799.
11. YANG, X., M. DOWNES, R.T. YU, et al. 2006. Nuclear receptor expression links the circadian clock to metabolism. Cell 126: 801-810.
12. PIKE, J. WESLEY, M.B. MEYER, M. WATANUKI, et al. 2007. Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptors. J. Steroid Biochem. Mol. Biol. 103: 389-95.
13. BONNELYE, E. & J.E. AUBIN. 2005. REVIEW: estrogen receptor-related receptor alpha: a mediator of estrogen response in bone. J. Biol. Chem. 280: 3104-3111.
14. MARGOLIS, R.N. & S.J. WIMALAWANSA. 2006. Novel targets and therapeutics for bone loss. Ann. N. Y. Acad. Sci. 1068: 402-409.
15. GIAGINIS, C., A. TSANTILI-KAKOULIDOU & S. THEOCHRARIS 2007. Peroxisome proliferator-activated receptor-γ ligands as bone turnover modulators. Exp. Opin. Investig. Drugs 16: 195-207.
16. GENNARI, L., V. DE PAOLA, D. MERLOTTI, et al. 2007. Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review. Exp. Opin. Pharmacother. 8: 537-553.
17. DOWNES, M., M.A. VERDECIA, A.J. ROECKER, et al. 2003. A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol. Cell 11: 1079-1092.
18. MARGOLIS, R.N., R.M. EVANS & B.W. O'MALLEY. 2005. The Nuclear Receptor Signaling Atlas: development of a functional atlas of nuclear receptors. Mol. Endocrinol. 19: 2433-2437.
19. LANZ, R.B., Z. JERICEVIC, W.J. ZUERCHER, et al. 2006. Nuclear Receptor Signaling Atlas (www.nursa.org): hyperlinking the Nuclear Receptor Signaling Community. Nucleic Acids Res. 34: D221-D226.
20. BARTHEL, T.K., D.R. MATHERN, G.K. WHITFIELD, et al. 2007. 1,25-dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism. J. Steroid Biochem. Mol. Biol. 103: 381-388.
21. YIN, L., J. WANG, P.S. KLEIN & M.A. LAZAR. 2006. Nuclear Receptor Rev-erba is a critical lithium-sensitive component of the Circadian Clock. Science 311: 1002-1005.
22. ABE, E., R.C. MARIANS, W. YU, et al. 2003. TSH is a negative regulator of skeletal remodeling. Cell 115: 151-162.
23. SUN, L., Y. PENG, A.C. SHARROW, et al. 2006. FSH directly regulates bone mass. Cell 125: 247-260.
24. ZAIDI, M. 2006. Skeletal development and remodeling in health, disease, and aging. Ann. N. Y. Acad. Sci. 1068: xiii-575.
25. CHRISTAKOS, S., P. DHAWAN, X. PENG, et al. 2007. New insights into the function and regulation of vitamin D target proteins. J. Steroid Biochem. Mol. Biol. 103: 405-410.
26. CANALIS, E., G. MASSIOTTI, A. GIUSTINA & J.P. BILEZIKIAN. 2007. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos. Int. DOI10.1007/s00198-007-0394-0.
27. KIM, H.-J., H. ZHAO, H. KITAURA, et al. 2006. Glucocorticoids suppress bone formation via the osteoclast. J. Clin. Invest. 116: 2152-2160.